[no definition available]
| Timeframe | Studies on this Protein(%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
|---|---|---|---|---|---|
| digallic acid | Human immunodeficiency virus 2 | IC50 | 2.5000 | 1 | 1 |
| methyl fluorone black | Human immunodeficiency virus 2 | IC50 | 1.9000 | 2 | 2 |
| 3,4,5-trihydroxybenzohydroxamic acid | Human immunodeficiency virus 2 | IC50 | 1.6000 | 2 | 2 |
| 4,5-di-O-caffeoylquinic acid | Human immunodeficiency virus 2 | IC50 | 0.5000 | 2 | 2 |
| nsc 158393 | Human immunodeficiency virus 2 | IC50 | 1.0000 | 1 | 1 |
| Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
|---|---|---|---|---|---|
| dolutegravir | Human immunodeficiency virus 2 | EC50 | 0.0023 | 1 | 1 |